Loading
companiesCompany
MRC Clinical Trials Unit at UCL
The MRC Clinical Trials Unit at UCL is the UK public trials unit that designed and ran STAMPEDE, FOCUS4, ICON7 and UKCTOCS; it marked 25 years in 2024 and became the UCL Innovative Clinical Trials Unit in April 2026.
Also called: Medical Research CouncilMRCMRC CTUMRC CTU at UCLUCL Innovative Clinical Trials UnitMRC Clinical Trials Unit
Overview
The MRC Clinical Trials Unit at UCL is a registered clinical trials unit (UKCRC Registered CTUs Network) at 90 High Holborn, London, that designs and conducts clinical trials, systematic reviews and observational studies; its website records a 25th anniversary in 2024 and says the unit became the UCL Innovative Clinical Trials Unit in April 2026, continuing the same mission. No founding year is stated on the pages read, so none is given here. ClinicalTrials.gov names the Medical Research Council (OTHER_GOV class) as lead sponsor of STAMPEDE (NCT00268476, the multi-arm platform trial in advanced prostate cancer); FOCUS4 (ISRCTN90061546, the biomarker-stratified colorectal cancer platform) is recorded in OnCo as run by the unit with Medical Research Council, NIHR and Cancer Research UK funding; ICON7 (recorded with GOG-0218, bevacizumab in ovarian cancer) and UKCTOCS (NCT00058032, ovarian cancer screening, registered by University College London with the Medical Research Council as collaborator) are its other OnCo trials. It has no products of its own.
Headquarters
London, GB
Website
Research output
From OpenAlex, oncology works in the last five years (2022 to 2026, current year in progress); counted on 2026-10-01.
Matched to MRC Clinical Trials Unit at UCL, including child institutions. 63 works · 762 citations · 78% open access · 21% clinical trials · 0% reviews.
Oncology works per year
262022
132023
82024
102025
62026
Most works
- Louise Clare Brown13 works
- Aleksandra Gentry‐Maharaj9 works
- Tim Maughan9 works
- Usha Menon8 works
- David J. Fisher7 works
- Duncan Charles Gilbert7 works
- Ruth Elizabeth Langley6 works
- Richard Adams6 works
- Philip Quirke6 works
- Matthew Robert Sydes6 works
Most cited
Similar pages
- CompanyARCAGY-GINECO
Shares GOG-0218 & ICON7 (bevacizumab), Ovarian cancer and the tag cooperative-group.
- CompanyGOG Foundation
Shares GOG-0218 & ICON7 (bevacizumab), Ovarian cancer and the tag cooperative-group.
- CompanyAGO Study Group
Shares Ovarian cancer and the tag cooperative-group.
- CompanyAustrian Breast & Colorectal Cancer Study Group
Shares Colorectal cancer and the tag cooperative-group.
- CompanyWest Japan Oncology Group
Shares Colorectal cancer and the tag cooperative-group.
- CompanyAIO (Arbeitsgemeinschaft Internistische Onkologie)
Shares Colorectal cancer and the tag cooperative-group.
- CompanyKorean Cancer Study Group
Shares Colorectal cancer and the tag cooperative-group.
- CompanyAustralasian Gastro-Intestinal Trials Group
Shares Colorectal cancer and the tag cooperative-group.
cancers
institutions
trials
An RCT of Concurrent and Maintenance Cediranib in Women With Platinum-sensitive Relapsed Ovarian CancerARTISTIC meta-analysisCombination Chemotherapy With or Without Bone Marrow Transplantation in Treating Children With Acute Myeloid LeukemiaCombination Chemotherapy, Biological Therapy, and Bone Marrow Transplantation in Treating Patients With Acute Myeloid LeukemiaFOCUS4GOG-0218 & ICON7 (bevacizumab)MRC COINMRC CR07Nottingham faecal occult blood screening trialPalliative Chemotherapy in Treating Patients With Advanced Colorectal CancerPATCH (Prostate Adenocarcinoma Transcutaneous Hormone)PT-1 (Primary Thrombocythaemia 1)QUARTZQUASARRADICALS-HDRADICALS-RTSTAMPEDEUKCTOCS